Author
Listed:
- Cassandra A. Simonich
(Fred Hutchinson Cancer Research Center
University of Washington School of Medicine)
- Laura Doepker
(Fred Hutchinson Cancer Research Center)
- Duncan Ralph
(Fred Hutchinson Cancer Research Center)
- James A. Williams
(University of Washington)
- Amrit Dhar
(Fred Hutchinson Cancer Research Center
University of Washington)
- Zak Yaffe
(University of Washington School of Medicine)
- Lauren Gentles
(University of Washington
Fred Hutchinson Cancer Research Center)
- Christopher T. Small
(Fred Hutchinson Cancer Research Center)
- Brian Oliver
(Center for Infectious Disease Research)
- Vladimir Vigdorovich
(Center for Infectious Disease Research)
- Vidya Mangala Prasad
(University of Washington)
- Ruth Nduati
(University of Nairobi)
- D. Noah Sather
(Center for Infectious Disease Research)
- Kelly K. Lee
(University of Washington)
- Frederick A. Matsen IV
(Fred Hutchinson Cancer Research Center)
- Julie Overbaugh
(Fred Hutchinson Cancer Research Center
University of Washington School of Medicine)
Abstract
HIV-infected infants develop broadly neutralizing plasma responses with more rapid kinetics than adults, suggesting the ontogeny of infant responses could better inform a path to achievable vaccine targets. Here we reconstruct the developmental lineage of BF520.1, an infant-derived HIV-specific broadly neutralizing antibody (bnAb), using computational methods developed specifically for this purpose. We find that the BF520.1 inferred naive precursor binds HIV Env. We also show that heterologous cross-clade neutralizing activity evolved in the infant within six months of infection and that, ultimately, only 2% SHM is needed to achieve the full breadth of the mature antibody. Mutagenesis and structural analyses reveal that, for this infant bnAb, substitutions in the kappa chain were critical for activity, particularly in CDRL1. Overall, the developmental pathway of this infant antibody includes features distinct from adult antibodies, including several that may be amenable to better vaccine responses.
Suggested Citation
Cassandra A. Simonich & Laura Doepker & Duncan Ralph & James A. Williams & Amrit Dhar & Zak Yaffe & Lauren Gentles & Christopher T. Small & Brian Oliver & Vladimir Vigdorovich & Vidya Mangala Prasad &, 2019.
"Kappa chain maturation helps drive rapid development of an infant HIV-1 broadly neutralizing antibody lineage,"
Nature Communications, Nature, vol. 10(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09481-7
DOI: 10.1038/s41467-019-09481-7
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-09481-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.